After compiling the data, we would like to first point out that suppressing the expression of the efflux transporters ABCB1, ABCC2, SLC25A21, and ATP7A has been linked to cisplatin’s accumulation and reduced resistance in urinary bladder cancer patients. Here, ABCC2 is linked to urinary bladder cancer.